Evidence map›Paper›PMID 38649651›Full record

ArticleNeurocritical care2024

Assessment of Blood Pressure and Heart Rate Related Variables in Acute Stroke Patients Receiving Intravenous Antihypertensive Medication Infusions.

Adnan I Qureshi, William I Baskett, Abdullah Lodhi, Francisco Gomez, Niraj Arora, Premkumar N Chandrasekaran, Farhan Siddiq, Camilo R Gomez, Chi-Ren Shyu

Abstract read
PubMed Publisher
In one paragraph

Article in Neurocritical care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Adnan I QureshiZeenat Qureshi Stroke Institute, ZQSI, St. Cloud, MN, USA. qureshai@gmail.com.ORCID 0000-0003-4962-540X
William I BaskettInstitute for Data Science and Informatics, University of Missouri, Columbia, MO, USA.
Abdullah LodhiZeenat Qureshi Stroke Institute, ZQSI, St. Cloud, MN, USA.
Francisco GomezDepartment of Neurology, University of Missouri, Columbia, MO, USA.
Niraj AroraDepartment of Neurology, University of Missouri, Columbia, MO, USA.
Premkumar N ChandrasekaranDepartment of Neurology, University of Missouri, Columbia, MO, USA.
Farhan SiddiqDivision of Neurosurgery, University of Missouri, Columbia, MO, USA.
Camilo R GomezDepartment of Neurology, University of Missouri, Columbia, MO, USA.
Chi-Ren ShyuInstitute for Data Science and Informatics, University of Missouri, Columbia, MO, USA.
University of Missouri · USCentraCare Health System · USMissouri College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe performed an analysis of a large intensive care unit electronic database to provide preliminary estimates of various blood pressure parameters in patients with acute stroke receiving intravenous (IV) antihypertensive medication and determine the relationship with in-hospital outcomes.

methodsWe identified the relationship between pre-treatment and post-treatment systolic blood pressure (SBP) and heart rate (HR)-related variables and in-hospital mortality and acute kidney injury in patients with acute stroke receiving IV clevidipine, nicardipine, or nitroprusside using data provided in the Medical Information Mart for Intensive Care (MIMIC) IV database.

resultsA total of 1830 patients were treated with IV clevidipine (n = 64), nicardipine (n = 1623), or nitroprusside (n = 143). The standard deviations [SDs] of pre-treatment SBP (16.3 vs. 13.7, p ≤ 0.001) and post-treatment SBP (15.4 vs. 14.4, p = 0.004) were higher in patients who died compared with those who survived, particularly in patients with intracerebral hemorrhage (ICH). The mean SBP was significantly lower post treatment compared with pre-treatment values for clevidipine (130.7 mm Hg vs. 142.5 mm Hg, p = 0.006), nicardipine (132.8 mm Hg vs. 141.6 mm Hg, p ≤ 0.001), and nitroprusside (126.2 mm Hg vs. 139.6 mm Hg, p ≤ 0.001). There were no differences in mean SDs post treatment compared with pre-treatment values for clevidipine (14.5 vs. 13.5, p = 0.407), nicardipine (14.2 vs. 14.6, p = 0.142), and nitroprusside (14.8 vs. 14.8, p = 0.997). The SDs of pre-treatment and post-treatment SBP were not significantly different in patients with ischemic stroke treated with IV clevidipine, nicardipine, or nitroprusside or for patients with ICH treated with IV clevidipine or nitroprusside. However, patients with ICH treated with IV nicardipine had a significantly higher SD of post-treatment SBP (13.1 vs. 14.2, p = 0.0032).

conclusionsWe found that SBP fluctuations were associated with in-hospital mortality in patients with acute stroke. IV antihypertensive medication reduced SBP but did not reduce SBP fluctuations in this observational study. Our results highlight the need for optimizing therapeutic interventions to reduce SBP fluctuations in patients with acute stroke.

Indexed as

Antihypertensive AgentsBlood PressureHeart RateNicardipineNitroprussideStrokeAgedAged, 80 and overCerebral HemorrhageFemaleHospital MortalityHumansHypertensionInfusions, IntravenousMaleMiddle AgedAntihypertensive AgentsclevidipineNicardipineNitroprussidePyridinesAcute strokeAntihypertensive medicationsBlood pressureFluctuationsIntravenous infusion

Identifiers

PMID38649651
OpenAlexW4395013244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.